Mar 19, 2025 04:00PM

Jul 27, 2023 04:33PM

Jul 27, 2023 04:00PM

May 16, 2023 04:00PM

Mar 29, 2023 04:00PM

Mar 23, 2023 05:00PM

Feb 14, 2023 05:00PM Correction: Inventiva reports preliminary financial results for Full-Year 2022¹

Feb 14, 2023 04:00PM

Nov 10, 2022 04:00PM

Oct 31, 2022 03:00AM

Sep 22, 2022 02:30AM

Sep 7, 2022 04:00PM

Jul 28, 2022 04:00PM

May 16, 2022 04:00PM Inventiva reports 2022 First Quarter Financial Information and provides clinical development update

Mar 7, 2022 04:26PM

Feb 28, 2022 04:00PM

Feb 14, 2022 04:00PM

Nov 10, 2021 04:00PM

Sep 20, 2021 04:13PM

Sep 20, 2021 04:10PM

Sep 10, 2021 09:00AM Inventiva’s 2021 First-Half Financial Results Presentation

Jul 28, 2021 04:00PM

Mar 5, 2021 03:43PM

Mar 5, 2021 02:25PM

Nov 12, 2020 04:00PM

Sep 16, 2020 04:00PM

Mar 10, 2020 12:45PM

Dec 18, 2019 12:28PM Inventiva announces positive results from Phase IIa clinical study with odiparcil in mucopolysaccharidosis type VI

Sep 26, 2017 12:30PM

Mar 27, 2017 01:30AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All